Neuroinflammation in Alzheimer's disease: different molecular targets and potential therapeutic agents including curcumin

Balmiki Ray, Debomoy Lahiri

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder of the elderly. Deposition of amyloid β plaque and associated neuroinflammation are the major hallmarks of AD. Whereas reactive oxygen species (ROS) and activated microglial cells contribute to neuronal loss, nuclear factor κB and apolipoprotein E participate in inflammatory process of AD. Current FDA approved drugs provide only symptomatic relief in AD. For broad spectrum of activity, some natural products are also being tested. Turmeric is used as an anti-inflammatory medicine in various regions of Asia. Curcumin, which is a yellow colored polyphenol compound present in turmeric, showed anti-inflammatory properties. Herein, we discuss the neurobiological and neuroinflammatory pathways of AD, evaluate different molecular targets and potential therapeutic agents, including curcumin, for the treatment of AD.

Original languageEnglish
Pages (from-to)434-444
Number of pages11
JournalCurrent Opinion in Pharmacology
Volume9
Issue number4
DOIs
StatePublished - Aug 2009

Fingerprint

Curcumin
Alzheimer Disease
Curcuma
Anti-Inflammatory Agents
Therapeutics
Amyloid Plaques
Polyphenols
Apolipoproteins E
Biological Products
Neurodegenerative Diseases
Reactive Oxygen Species
Medicine
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology

Cite this

@article{8bc9c5b444e5462886f1cc41e398b701,
title = "Neuroinflammation in Alzheimer's disease: different molecular targets and potential therapeutic agents including curcumin",
abstract = "Alzheimer's disease (AD) is a neurodegenerative disorder of the elderly. Deposition of amyloid β plaque and associated neuroinflammation are the major hallmarks of AD. Whereas reactive oxygen species (ROS) and activated microglial cells contribute to neuronal loss, nuclear factor κB and apolipoprotein E participate in inflammatory process of AD. Current FDA approved drugs provide only symptomatic relief in AD. For broad spectrum of activity, some natural products are also being tested. Turmeric is used as an anti-inflammatory medicine in various regions of Asia. Curcumin, which is a yellow colored polyphenol compound present in turmeric, showed anti-inflammatory properties. Herein, we discuss the neurobiological and neuroinflammatory pathways of AD, evaluate different molecular targets and potential therapeutic agents, including curcumin, for the treatment of AD.",
author = "Balmiki Ray and Debomoy Lahiri",
year = "2009",
month = "8",
doi = "10.1016/j.coph.2009.06.012",
language = "English",
volume = "9",
pages = "434--444",
journal = "Current Opinion in Pharmacology",
issn = "1471-4892",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - Neuroinflammation in Alzheimer's disease

T2 - different molecular targets and potential therapeutic agents including curcumin

AU - Ray, Balmiki

AU - Lahiri, Debomoy

PY - 2009/8

Y1 - 2009/8

N2 - Alzheimer's disease (AD) is a neurodegenerative disorder of the elderly. Deposition of amyloid β plaque and associated neuroinflammation are the major hallmarks of AD. Whereas reactive oxygen species (ROS) and activated microglial cells contribute to neuronal loss, nuclear factor κB and apolipoprotein E participate in inflammatory process of AD. Current FDA approved drugs provide only symptomatic relief in AD. For broad spectrum of activity, some natural products are also being tested. Turmeric is used as an anti-inflammatory medicine in various regions of Asia. Curcumin, which is a yellow colored polyphenol compound present in turmeric, showed anti-inflammatory properties. Herein, we discuss the neurobiological and neuroinflammatory pathways of AD, evaluate different molecular targets and potential therapeutic agents, including curcumin, for the treatment of AD.

AB - Alzheimer's disease (AD) is a neurodegenerative disorder of the elderly. Deposition of amyloid β plaque and associated neuroinflammation are the major hallmarks of AD. Whereas reactive oxygen species (ROS) and activated microglial cells contribute to neuronal loss, nuclear factor κB and apolipoprotein E participate in inflammatory process of AD. Current FDA approved drugs provide only symptomatic relief in AD. For broad spectrum of activity, some natural products are also being tested. Turmeric is used as an anti-inflammatory medicine in various regions of Asia. Curcumin, which is a yellow colored polyphenol compound present in turmeric, showed anti-inflammatory properties. Herein, we discuss the neurobiological and neuroinflammatory pathways of AD, evaluate different molecular targets and potential therapeutic agents, including curcumin, for the treatment of AD.

UR - http://www.scopus.com/inward/record.url?scp=68849128791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68849128791&partnerID=8YFLogxK

U2 - 10.1016/j.coph.2009.06.012

DO - 10.1016/j.coph.2009.06.012

M3 - Article

C2 - 19656726

AN - SCOPUS:68849128791

VL - 9

SP - 434

EP - 444

JO - Current Opinion in Pharmacology

JF - Current Opinion in Pharmacology

SN - 1471-4892

IS - 4

ER -